These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38504134)

  • 41. Melanocortin-4 Receptor Signalling: Importance for Weight Regulation and Obesity Treatment.
    Kühnen P; Krude H; Biebermann H
    Trends Mol Med; 2019 Feb; 25(2):136-148. PubMed ID: 30642682
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sequencing methods, functional characterization, prevalence, and penetrance of rare coding mutations in panels of monogenic obesity genes from the leptin-melanocortin pathway: A systematic review.
    Dosda S; Renard E; Meyre D
    Obes Rev; 2024 Aug; 25(8):e13754. PubMed ID: 38779716
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mendelian obesity, molecular pathways and pharmacological therapies: a review.
    Paolacci S; Borrelli A; Stuppia L; Campanile FC; Dallavilla T; Krajčovič J; Veselenyiova D; Beccari T; Unfer V; Bertelli M;
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1357-1378. PubMed ID: 30779104
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic strategies to understand physiological pathways regulating body weight.
    Farooqi S
    Mamm Genome; 2014 Oct; 25(9-10):377-83. PubMed ID: 25154910
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The genetics of obesity].
    Hagymási K; Tulassay Z
    Orv Hetil; 2006 Jan; 147(3):107-13. PubMed ID: 16515029
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetics of Obesity.
    Kleinendorst L; van Haelst MM; van den Akker ELT
    Exp Suppl; 2019; 111():419-441. PubMed ID: 31588542
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Associations between obesity candidate gene polymorphisms (fat mass and obesity-associated (FTO), melanocortin-4 receptor (MC4R), leptin (LEP) and leptin receptor (LEPR)) and dietary intake in pregnant women.
    Martins MC; Trujillo J; Freitas-Vilela AA; Farias DR; Rosado EL; Struchiner CJ; Kac G
    Br J Nutr; 2018 Aug; 120(4):454-463. PubMed ID: 29893663
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Obesity induced by abnormality in leptin receptor and melanocortin-4 receptor].
    Shintani M; Ogawa Y; Nakao K
    Nihon Rinsho; 2002 Feb; 60(2):404-9. PubMed ID: 11857934
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetics of human obesity.
    Mutch DM; Clément K
    Best Pract Res Clin Endocrinol Metab; 2006 Dec; 20(4):647-64. PubMed ID: 17161337
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic approaches to understanding human obesity.
    Ramachandrappa S; Farooqi IS
    J Clin Invest; 2011 Jun; 121(6):2080-6. PubMed ID: 21633175
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human obesity and insulin resistance: lessons from experiments of nature.
    O'Rahilly S
    Biochem Soc Trans; 2007 Feb; 35(Pt 1):33-6. PubMed ID: 17212584
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Genetic causes of obesity].
    Wangensteen T; Undlien D; Tonstad S; Retterstøl L
    Tidsskr Nor Laegeforen; 2005 Nov; 125(22):3090-3. PubMed ID: 16299561
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The genetics of human monogenic obesity].
    Zhang CB; Wu HL
    Yi Chuan Xue Bao; 2004 Aug; 31(8):864-9. PubMed ID: 15481544
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acquired hypothalamic obesity: A clinical overview and update.
    Roth CL; McCormack SE
    Diabetes Obes Metab; 2024 Apr; 26 Suppl 2():34-45. PubMed ID: 38450938
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Obesity caused by melanocortin-4 receptor mutations].
    van den Berg L; Glorie-Docter M; van den Akker E; Delemarre-van de Waal HA
    Ned Tijdschr Geneeskd; 2012; 156(32):A4548. PubMed ID: 22871247
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Genetic obesity: new diagnostic options].
    de Vries TI; Alsters SI; Kleinendorst L; van Haaften G; van der Zwaag B; Van Haelst MM
    Ned Tijdschr Geneeskd; 2017; 161():D688. PubMed ID: 28351432
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The central melanocortin system as a treatment target for obesity and diabetes: A brief overview.
    Goit RK; Taylor AW; Lo ACY
    Eur J Pharmacol; 2022 Jun; 924():174956. PubMed ID: 35430211
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Melanocortin potentiates leptin-induced STAT3 signaling via MAPK pathway.
    Zhang Y; Wu X; He Y; Kastin AJ; Hsuchou H; Rosenblum CI; Pan W
    J Neurochem; 2009 Jul; 110(1):390-9. PubMed ID: 19457101
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The central melanocortin system and human obesity.
    Yang Y; Xu Y
    J Mol Cell Biol; 2020 Oct; 12(10):785-797. PubMed ID: 32976556
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The complex web of obesity: from genetics to precision medicine.
    M JN; Bharadwaj D
    Expert Rev Endocrinol Metab; 2024 Jun; ():1-16. PubMed ID: 38869356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.